DEVELOPING AN ORGANOID MODEL TO UNDERSTAND THE BAT GASTROINTESTINAL EPITHELIAL RESPONSE TO THE SEVER ACUTE RESPIRATORY CORONA VIRUS-2 (SARS-COV-2)

ABSTRACT

The ongoing COVID-19 pandemic is caused by the severe acute respiratory corona virus-2 (SARS-CoV-2) which as of right now has infected 10% of world’s population and has caused >1.5 million deaths worldwide. In addition to respiratory symptoms, COVID-19 causes nausea, vomiting and diarrhea in more than half of infected subjects. This indicates that SARS-CoV-2 not only infects the respiratory tract, but also the gastrointestinal. Bats are thought to be the original reservoir for SARS-CoV-2, since SARS-CoV-2 is 96% identical to the bat coronavirus RatG13, which was identified in horseshoe bats. However, coronaviruses fail to cause overt disease in the bats, whereas strong cytopathic effects were observed in human respiratory and gastrointestinal epithelial cells upon SARS-CoV-2 infection. The goal of our research is to compare the response of primary intestinal epithelial cells of bats and humans to SARS-CoV-2 infection in order to better understand the cellular mechanism that allow bats to harbor coronaviruses without developing disease symptoms. To study the SARS-Co-V-2 infection in bats, we have, for the first time, established organoids lines from the stomach, proximal and distal small intestine of three adult Jamaican Fruit Bats (Artibeus jamaicensis). Organoids were successfully generated from both fresh and frozen tissue and could be passaged at least 25 times and frozen and thawed with no apparent changes in growth and morphology. Microscopic analysis showed that bat gastric and intestinal organoids were composed of a simple columnar epithelium and secreted variable amounts of mucus. We also observed spontaneous development of gland and crypt structures, indicating appropriate differentiation (Fig. 1). When seeded on transwell inserts, both gastric and intestinal organoid cells consistently developed a transepithelial resistance, demonstrating intact barrier function. Using confocal microscopy, we showed that both gastric and intestinal organoids from bats expressed angiotensin I converting enzyme 2 (ACE2), a key receptor for SARS-CoV-2 entry. Our innovative experimental platform will enable us to study multiple aspects of coronavirus infection including viral evolution and determinants of spillover events in a relevant primary cell model system. Importantly, we will utilize the bat organoid model to identify nonpathogenic cellular pathways that enable tolerance to SARS-CoV-2 in the reservoir hosts for this virus, potentially informing novel treatment strategies in human COVID-19 patients.